Your session is about to expire
← Back to Search
Other
TENS for Stroke (TENS Trial)
N/A
Recruiting
Led By Yasin Dhaher, Ph.D.
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group
Summary
"This trial involves participants attending at least 15 sessions for various tests related to reflex behaviors, motor tracts, functional movement, and walking patterns. Each participant will be enrolled and data collected over a four
Who is the study for?
This trial is for post-stroke patients who have hemiplegia or paresis, which means they've lost some muscle control on one side of their body. Participants should be able to commit to at least 15 sessions over four months.
What is being tested?
The study tests the effects of a Transcutaneous Electrical Nerve Stimulation (TENS) device called InTENSity 10 on stroke recovery. It involves various tests to see how it affects reflexes, motor neuron activity, and walking patterns after a stroke.
What are the potential side effects?
While not specified here, TENS devices can sometimes cause skin irritation where the pads are placed, muscle twitching during use, and in rare cases may lead to an allergic reaction to pad materials.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adaptation Testing
Reflex Testing
Walking Testing
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Post Stroke - individuals with history of single unilateral stroke (>6 months since onset)Experimental Treatment1 Intervention
Individuals, aged 18-80, male or female, with a history of single unilateral stroke with subsequent lower limb hemiparesis on either side (\>6 months since onset)
Find a Location
Who is running the clinical trial?
University of Texas Southwestern Medical CenterLead Sponsor
1,088 Previous Clinical Trials
1,059,610 Total Patients Enrolled
Yasin Dhaher, Ph.D.Principal InvestigatorUniversity of Texas Southwestern Medical Center
3 Previous Clinical Trials
136 Total Patients Enrolled